Indice/Contents

Transcript

Indice/Contents
I tumori in Italia • Rapporto AIRTUM 2014 • PREVALENZA
Indice
WWW.EPIPREV.IT
Contents
PREFAZIONE. Centro nazionale per la prevenzione e il controllo delle malattie (CCM)
FOREWORD. National Centre for Disease Prevention and Control
......................................................
5
PREFAZIONE. Associazione nazionale guariti o lungoviventi oncologici (ANGOLO)
FOREWORD. National association of cured or long-survivor cancer patients
...........................................
7
INTRODUZIONE. Associazione italiana dei registri tumori (AIRTUM)
INTRODUCTION. Italian Association of Cancer Registries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
RIASSUNTO / ABSTRACT
..............................................................................................
11
1 SINTESI DEL RAPPORTO
EXTENDED SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2 MATERIALI E METODI
MATERIALS AND METHODS
........................................................................................
28
3 GUIDA ALLA LETTURA DELLE SCHEDE SPECIFICHE PER TUMORE
A GUIDE TO THE CANCER-SPECIFIC DATA SHEETS
...............................................................
40
4 RISULTATI: SCHEDE SPECIFICHE PER TUMORE
RESULTS: CANCER-SPECIFIC DATA SHEETS
TUMORE DELLA LARINGE
TUTTI I TUMORI
ALL TYPES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
TUMORE DELLA TESTA
E DEL COLLO
HEAD AND NECK CANCER
TONGUE CANCER . . . . . . . . . . . . . . . . . . . . . . . 46
TUMORE DELLE GHIANDOLE
SALIVARI
OROPHARYNX CANCER . . . . . . . . . . . . . . . . 49
. . . . . . . . . . . . . . 50
MELANOMA DELLA PELLE
LINFOMA DI HODGKIN
MESOTELIOMA
LINFOMA NON-HODGKIN
. . . . . . . . . . . . . . . . . . . . . . . . 68
KAPOSI SARCOMA . . . . . . . . . . . . . . . . . . . . . . 69
TUMORE DEL TESSUTO
CONNETTIVO
. . . . . . . . . . . . . . 51
TUMORE DELL’ESOFAGO
CONNECTIVE TISSUE CANCER
. . . . . . . . . . . . . . . . 52
BRAIN AND CENTRAL
NERVOUS SYSTEM CANCER . . . . . . . . . . . 82
TUMORE DELLA TIROIDE
. . . . . . . . . . . . . . . . . . . . . . . . . . 66
SARCOMA DI KAPOSI
TUMORE DELL’IPOFARINGE
CHOROIDAL MELANOMA . . . . . . . . . . . . . . 81
TUMORE DELL’OSSO
MESOTHELIOMA
TUMORE DELLA RINOFARINGE
OESOPHAGUS CANCER
. . . . . . . . . . . . . . . 65
SKIN MELANOMA . . . . . . . . . . . . . . . . . . . . . . . 67
TUMORE DELL’OROFARINGE
HYPOPHARYNX CANCER
TUMORE DI TIMO, CUORE,
MEDIASTINO
TUMORE DELL’ENCEFALO
E DEL SISTEMA
NERVOSO CENTRALE
BONE CANCER
. . . . . . . . . . 48
TUMORE DELLA VESCICA
MELANOMA DELLA COROIDE
THYMUS, HEART,
MEDIASTINUM CANCER
TUMORE DELLA BOCCA
MOUTH CANCER . . . . . . . . . . . . . . . . . . . . . . . . 47
. . . . . . . . 70
43
BLADDER CANCER . . . . . . . . . . . . . . . . . . . . . . 80
TUMORE DI POLMONI,
BRONCHI, TRACHEA
LUNG, BRONCHUS,TRACHEA CANCER ..64
TUMORE DELLA LINGUA
NASOPHARYNX CANCER
. . . . . . . . . . . . . . . . . . . . . . . 63
LARYNX CANCER
. . . . . . . . . . . . 45
SALIVARY GLANDS CANCER
.......................................................................
THYROID CANCER
. . . . . . . . . . . . . . . . . . . . . . 83
HODGKIN LYMPHOMA
. . . . . . . . . . . . . . . . . 84
NON-HODGKIN LYMPHOMA
. . . . . . . . . . 85
LEUCEMIA LINFATICA CRONICA
/LINFOMA A PICCOLI LINFOCITI B
CHRONIC LYMPHOCYTIC LEUKAEMIA
/SMALL LYMPHOCYTIC LYMPHOMA . . 86
TUMORE DELLA MAMMELLA
FEMMINILE
LINFOMA DIFFUSO
A GRANDI CELLULE B
TUMORE DI VAGINA E VULVA
VAGINA AND VULVA CANCER . . . . . . . . . 72
LINFOMA FOLLICOLARE
TUMORE DI COLON, RETTO, ANO
COLON, RECTUM, ANUS CANCER . . . . 55
TUMORE DELLA CERVICE
UTERINA
NEOPLASIE PLASMACELLULARI
/MIELOMA MULTIPLO
TUMORE DEL COLON
TUMORE DELL’ENDOMETRIO
TUMORE DELLO STOMACO
STOMACH CANCER . . . . . . . . . . . . . . . . . . . . . 53
FEMALE BREAST CANCER
TUMORE DELL’INTESTINO
TENUE
SMALL INTESTINE CANCER . . . . . . . . . . . . 54
COLON CANCER
CERVIX UTERI CANCER
. . . . . . . . . . . . . . . . . . . . . . . . 56
CORPUS UTERI CANCER
TUMORE DEL RETTO
. . . . . . . . . . . . . . . . 73
. . . . . . . . . . . . . . . 74
RECTUM CANCER . . . . . . . . . . . . . . . . . . . . . . . 57
TUMORE DELL’OVAIO
TUMORE DELL’ANO
TUMORE DEL PENE
ANUS CANCER
. . . . . . . . . . . . . 71
OVARY CANCER . . . . . . . . . . . . . . . . . . . . . . . . . 75
. . . . . . . . . . . . . . . . . . . . . . . . . . 58
PENIS CANCER
. . . . . . . . . . . . . . . . . . . . . . . . . . 76
DIFFUSE LARGE
B-CELL LYMPHOMA . . . . . . . . . . . . . . . . . . . . . 87
FOLLICULAR B-CELL LYMPHOMA . . . . . 88
MULTIPLE MYELOMA
(PLASMA CELL) . . . . . . . . . . . . . . . . . . . . . . . . . . 89
LEUCEMIE
LEUKAEMIAS
. . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
LINFOMA/LEUCEMIA
LINFOBLASTICA ACUTA
A CELLULE PROGENITRICI
TUMORE DEL FEGATO
TUMORE DELLA PROSTATA
PROSTATE CANCER . . . . . . . . . . . . . . . . . . . . . 77
PRECURSOR CELL
ACUTE LYMPHOBLASTIC
LYMPHOMA/LEUKAEMIA
TUMORE DELLE COLECISTI
TUMORE DEL TESTICOLO
LEUCEMIA MIELOIDE ACUTA
TUMORE DEL RENE
E DEGLI ALTRI ORGANI URINARI
LEUCEMIA MIELOIDE
CRONICA
LIVER CANCER
. . . . . . . . . . . . . . . . . . . . . . . . . . 59
GALLBLADDER CANCER
. . . . . . . . . . . . . . . 60
TESTIS CANCER
TUMORE DEL PANCREAS
PANCREAS CANCER . . . . . . . . . . . . . . . . . . . . 61
TUMORE DELLE CAVITÀ NASALI
NASAL CAVITIES CANCER . . . . . . . . . . . . . 62
Epidemiol Prev 38 (6) Suppl 1:1-144
. . . . . . . . . . . . . . . . . . . . . . . . . 78
KIDNEY AND OTHER URINARY
ORGANS CANCER . . . . . . . . . . . . . . . . . . . . . . . 79
3
. . . . . . . . . . . . . . 91
ACUTE MYELOID LEUKAEMIA . . . . . . . . . 92
CHRONIC MYELOID
LEUKAEMIA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
® Ulteriori dati disponibili sul sito: www.registri-tumori.it
I tumori in Italia • Rapporto AIRTUM 2014 • PREVALENZA
5 PROIEZIONI DELLA PREVALENZA DEI TUMORI IN ITALIA AL 2015
WWW.EPIPREV.IT
PROJECTIONS OF CANCER PREVALENCE IN ITALY FOR 2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
6 PERSONE VIVE DOPO UNA DIAGNOSI DI TUMORE IN ETÀ PEDIATRICA
PEOPLE LIVING AFTER CANCER IN CHILDHOOD
................................................................
101
7 UN NUOVO INDICATORE PER DIFFERENZIARE LA PREVALENZA DEI TUMORI
IN BASE ALLO STATO DI SALUTE
A NEW INDICATOR FOR DIFFERENTIATING CANCER PREVALENCE ACCORDING TO HEALTH STATUS
......
106
8 LA VALUTAZIONE ECONOMICA DEI PERCORSI DI CURA DEI PAZIENTI ONCOLOGICI
ECONOMIC EVALUATION OF PATTERNS OF CARE FOR CANCER PATIENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
9 PREVALENZA COMPLETA PER TUMORE IN ITALIA:
CONFRONTO TRA STIME BASATE SUI DATI DEI REGISTRI E STIME MIAMOD . . . . . . . . . . . . . 114
COMPLETE CANCER PREVALENCE IN ITALY: COMPARISON OF REGISTRY-BASED AND MIAMOD ESTIMATES
10 PREVALENZA DEI TUMORI RARI IN ITALIA
RARE CANCER PREVALENCE IN ITALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
COMMENTI DA ALTRE ASSOCIAZIONI SCIENTIFICHE E DI PAZIENTI
COMMENTS FROM OTHER SCIENTIFIC ASSOCIATIONS AND PATIENTS’ ORGANISATIONS
11 IL PUNTO DI VISTA DEGLI ONCOLOGI MEDICI Stefano Cascinu
THE POINT OF VIEW OF MEDICAL ONCOLOGISTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
12 BISOGNI PSICOSOCIALI E DIRITTO ALLA SALUTE EMOZIONALE
NELLA LUNGOSOPRAVVIVENZA E GUARIGIONE DAL CANCRO Luigi Grassi, Anna Costantini
PSYCHOSOCIAL NEEDS AND WELL-BEING ISSUES OF LONG-TERM SURVIVORS
AND CURED CANCER PATIENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
13 IL PUNTO DI VISTA DEL VOLONTARIATO ONCOLOGICO Francesco De Lorenzo
THE POINT OF VIEW OF PATIENTS’ ORGANISATIONS
...........................................................
130
APPENDICI
APPENDICES
1. CASI INCIDENTI PER TIPO DI CANCRO, AREA, SESSO ED ETÀ
INCIDENT CASES BY CANCER TYPE, AREA, GENDER, AND AGE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134
2. POPOLAZIONE COPERTA DAI REGISTRI TUMORI INCLUSI NELLO STUDIO
POPULATION OF ITALIAN CANCER REGISTRIES INCLUDED IN THE PRESENT REPORT
.......................
136
3. POPOLAZIONE ITALIANA PER REGIONE E MACROAREA
OVERALL POPULATION OF ITALIAN REGIONS AND MACROAREAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
4. LA RETE DEI REGISTRI AIRTUM
THE NETWORK OF THE AIRTUM CANCER REGISTRIES
..........................................................
141
MATERIALE AGGIUNTIVO
SUPPLEMENTARY MATERIAL
ON-LINE http://www.registri-tumori.it and http://www.epiprev.it
PREVALENZA COMPLETA PER TEMPO DALLA DIAGNOSI, SESSO, ETÀ, AREA E SINGOLO REGISTRO
PREVALENCE BY TIME SINCE DIAGNOSIS, SEX, AGE, AREA, AND CANCER REGISTRY
FINANZIAMENTI. Questa monografia è frutto del lavoro svolto dall'Associazione italiana dei registri tumori (AIRTUM)
con il supporto economico dell'Associazione italiana per la ricerca sul cancro (AIRC, grant n. 11859) e del Centro nazionale
per la prevenzione e il controllo delle malattie (CCM), Ministero della salute.
AIRTUM ha ricevuto un contributo economico da ROCHE SpA per la stampa e la distribuzione del volume.
Gli sponsor non hanno avuto alcun ruolo nella conduzione dello studio e nella scrittura del lavoro.
FUNDING DISCLOSURE. The content of this report is the result of the work of the Italian Association of Cancer Registries (AIRTUM)
which was supported by the Italian Association of Cancer Research (AIRC, grant No. 11859) and CCM, Italian Health Ministry.
AIRTUM received financial support for printing and distributing this Monograph by ROCHE SpA.
The sponsors had no role in the conduct of the study and in writing this report.
Epidemiol Prev 38 (6) Suppl 1:1-144
4
® Ulteriori dati disponibili sul sito: www.registri-tumori.it

Documenti analoghi

slide

slide • Six years after surgery, the probability of returning to work was still only half as high among breast cancer survivors than among controls. • The main predictor for not returning to work was fou...

Dettagli

Presentazione di PowerPoint - ANDI

Presentazione di PowerPoint - ANDI Highest rates were observed in 3 developing countries (Pakistan, Brazil, and India) and in 1 developed country (France). A higher proportion of clinically diagnosed cases is observed in both lowan...

Dettagli